Arcadia Biosciences (RKDA) Accumulated Expenses (2014 - 2025)

Arcadia Biosciences' Accumulated Expenses history runs 12 years deep, the most recent figure standing at $107000.0 for Q4 2025.

• Quarterly Accumulated Expenses fell 88.88% year-over-year to $107000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $107000.0 (down 88.88% YoY) and the FY2025 annual result came in at $107000.0, down 88.88% from the prior year.
• Accumulated Expenses was $107000.0 for Q4 2025 at Arcadia Biosciences, down from $962000.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.6 million in Q4 2021 and bottomed at $107000.0 in Q4 2025.
• A 5-year average of $1.0 million and a median of $1.1 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2021 — Accumulated Expenses soared 3468.89% — and 2025, when it tumbled 88.88%.
• Arcadia Biosciences' Accumulated Expenses stood at $1.6 million in 2021, then fell by 14.51% to $1.4 million in 2022, then retreated by 18.5% to $1.1 million in 2023, then fell by 14.03% to $962000.0 in 2024, then tumbled by 88.88% to $107000.0 in 2025.
• Business Quant data shows RKDA's Accumulated Expenses at $107000.0 in Q4 2025, $962000.0 in Q4 2024, and $1.1 million in Q4 2023.